Answers are grounded in this paper and cite their sources.
The transcription factor forkhead box P3 (FOXP3) has been identified as a marker of CD4+CD25+ regulatory T cells and is a key determinant of their immunosuppressive functions. FOXP3 has indeed been shown to limit antitumor immune responses during tumor progression. In addition, by expressing FOXP3, tumor cells may evade effector T-cell responses.
No takes yet. Share an insight, caveat, or question.
Grimmig et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: